In NSCLC, the TGFβ/TGFR pathway is considered as a tumor promoter, and the increasing TGFβ1 expression by tumor cells correlated with tumor progression and metastasis in lung cancer [33]. This evidence concerns the gene TGFB1 and lung carcinoma.